Surprisingly, the difference in OS was highly significant with 15 months in the DOAC cohort vs. 9 months in the LMWH.
← all excerpts
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma.
1
—
—